Trading Concept
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Trading Concept
No Result
View All Result
Home Trading News

Biden expected to pick former FDA Commissioner Dr. Robert Califf to run the agency

by
November 12, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Is 1000pip Climber System The Best Forex Signals Provider? A Comprehensive Review

Is Tiller The Best Net Worth Tracker? The Rise of Digital Financial Management

Dr. Robert Califf testifies during his nomination hearing before the Senate Health, Education, Labor and Pensions Committee November 17, 2015 in Washington, DC.

Win McNamee | Getty Images

President Joe Biden is expected to pick Dr. Robert Califf to serve as the chief of the Food and Drug Administration, NBC News reported Friday, citing people familiar with the selection process.

The FDA, currently overseen by acting Commissioner Dr. Janet Woodcock, has been without a permanent chief since Biden took office in January. The White House reportedly ruled out Woodcock after she faced opposition from some members of Congress over her handling of opioids while at the agency.

Califf, a cardiologist who works at the Duke University School of Medicine, was briefly the agency’s commissioner under the Obama administration beginning in 2016. He also served as deputy commissioner of the FDA’s medical products and tobacco office.

The new selection is expected imminently because Woodcock cannot legally stay on as the acting head past Nov. 15 without a nominee to hold the position permanently.

Biden’s expected nomination comes amid the ongoing Covid-19 pandemic, which has killed at least 759,678 Americans, according to data compiled by Johns Hopkins University.

The FDA has helped bring lifesaving treatments to the market and authorized the use of Covid vaccines, which have shown to be highly effective, especially against severe disease, hospitalization and death.

More than 194 million Americans are fully vaccinated against Covid, according to data compiled by the Centers for Disease Control and Prevention.

The FDA has recently come under harsh criticism, though, over its decision to approve Biogen’s Alzheimer’s drug, Aduhelm.

ShareTweetPin

Related Posts

Is 1000pip Climber System The Best Forex Signals Provider? A Comprehensive Review

by
October 1, 2023
0

The forex market is a fast-paced environment where traders constantly seek an edge to make profitable decisions. Central to this...

Is Tiller The Best Net Worth Tracker? The Rise of Digital Financial Management

by
October 1, 2023
0

Understanding one’s net worth is more than just knowing how much one has in the bank. It’s a comprehensive snapshot...

Is SoFi Invest The Best Automated Trading Software? Unraveling the Truth

by
October 1, 2023
0

As traditional investment avenues have expanded and evolved, automated trading software and micro-investing apps have become popular. These platforms simplify...

Is StreetBeat The Best Automated Trading Software? Insights from Everyday Traders

by
October 1, 2023
0

Automated trading software offer a seamless blend of technology and strategy. They allow novice and seasoned traders to optimize their...

Is TradingView The Best Automated Trading Software? The Ultimate Analysis Guide

by
October 1, 2023
0

With the rapid advancements in technology, traders now have many platforms at their fingertips catering to their specific needs and...

Next Post

Q4 GDP Forecasts: Around 5% to 6%

Why This IBM Spinoff Is Struggling

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • WHO says Covid vaccine booster programs will prolong pandemic

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Spin or Split? AT&T Has a Big Decision to Make on Discovery Stake.

    0 shares
    Share 0 Tweet 0
  • Here’s how Carl Icahn is positioning for a possible recession in America

    0 shares
    Share 0 Tweet 0
  • Some lawmakers and their families are betting thousands of dollars on crypto

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by tradingconcept.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.tradingconcept.net